Home / Inspections / 1088003

FDA Inspection 1088003 — IBSA Institut Biochimique SA

IBSA Institut Biochimique SA — FEI 3002864272

The FDA completed an inspection of IBSA Institut Biochimique SA on March 28, 2019 in Pazzallo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pazzallo (Switzerland)

Additional Details

Clinical BA/BE

Facility

Other inspections at this facility

  • 1201222 (VAI Fri Mar 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1056552 (VAI Fri Jun 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 981959 (NAI Fri Jul 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938124 (NAI Thu Jul 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853655 (NAI Fri Sep 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources